Downregulation of microRNA-383 is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation by targeting IRF1

Cell Death and Disease

Volumn 1, Issue 11, 2010, Pages

  Lian, J ^a   Tian, H ^a   Liu, L ^a   Zhang, X S ^b   Li, W Q ^a   Deng, Y M ^a   Yao, G D ^a,c   Yin, M M ^a   Sun, F ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c Hefei Maternal and Child Health Hospital   (China)

Author keywords

Apoptosis; Cell cycle; IRF1; Male infertility; miR 383

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; INTERFERON REGULATORY FACTOR 1; MICRORNA 383; PROTEASOME; PROTEIN P21; RETINOBLASTOMA PROTEIN; RNA; UNCLASSIFIED DRUG; CYCLIN DEPENDENT KINASE INHIBITOR 1A; IRF1 PROTEIN, HUMAN; MICRORNA; MIRN383 MICRORNA, HUMAN;

ADULT; ANIMAL CELL; APOPTOSIS; ARTICLE; AZOOSPERMIA; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DOWN REGULATION; EMBRYONAL CARCINOMA STEM CELL; GENE SILENCING; GERM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MALE INFERTILITY; MATURATION ARREST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA STABILITY; UPREGULATION; ANIMAL; CYTOLOGY; EMBRYONAL CARCINOMA; GENETICS; METABOLISM; PHOSPHORYLATION; TESTIS TUMOR; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARCINOMA, EMBRYONAL; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; EMBRYONAL CARCINOMA STEM CELLS; G1 PHASE; HUMANS; INFERTILITY, MALE; INTERFERON REGULATORY FACTOR-1; MALE; MICE; MICRORNAS; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; TESTICULAR NEOPLASMS;

EID: 79958715481     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2010.70     Document Type: Article

References (40)

1. Matzuk MM, Lamb DJ. Genetic dissection of mammalian fertility pathways. Nat Cell Biol 2002; 4 (Suppl): s41-s49. (Pubitemid 35175933)
2. Hung AJ, King P, Schlegel PN. Uniform testicular maturation arrest: a unique subset of men with nonobstructive azoospermia. J Urol 2007; 178: 608-612; discussion 612. (Pubitemid 47039162)
3. Lin WW, Lamb DJ, Lipshultz LI, Kim ED. Demonstration of testicular apoptosis in human male infertility states using a DNA laddering technique. Int Urol Nephrol 1999; 31: 361-370.
4. Steger K, Aleithe I, Behre H, Bergmann M. The proliferation of spermatogonia in normal and pathological human seminiferous epithelium: an immunohistochemical study usingmonoclonal antibodies against Ki-67 protein and proliferating cell nuclear antigen. Mol Hum Reprod 1998; 4: 227-233. (Pubitemid 28172588)
5. Bar-Shira Maymon B, Yogev L, Yavetz H, Lifschitz-Mercer B, Schreiber L, Kleiman SE et al. Spermatogonial proliferation patterns in men with azoospermia of different etiologies. Fertil Steril 2003; 80: 1175-1180. (Pubitemid 37377746)
6. Gonsalves J, Sun F, Schlegel PN, Turek PJ, Hopps CV, Greene C et al. Defective recombination in infertile men. Hum Mol Genet 2004; 13: 2875-2883. (Pubitemid 39562551)
7. Sun F, Kozak G, Scott S, Trpkov K, Ko E, Mikhaail-Philips M et al. Meiotic defects in a man with non-obstructive azoospermia: case report. Hum Reprod 2004; 19: 1770-1773. (Pubitemid 39144620)
8. Braun RE. Post-transcriptional control of gene expression during spermatogenesis. Semin Cell Dev Biol 1998; 9: 483-489. (Pubitemid 128350676)
9. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
10. Hayashi K, Chuva de Sousa Lopes SM, Kaneda M, Tang F, Hajkova P, Lao K et al. MicroRNA biogenesis is required for mouse primordial germ cell development and spermatogenesis. PLoS One 2008; 3: e1738.
11. Maatouk DM, Loveland KL, McManus MT, Moore K, Harfe BD. Dicer1 is required for differentiation of the mouse male germline. Biol Reprod 2008; 79: 696-703.
12. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 2006; 124: 1169-1181.
13. Lian J, Zhang X, Tian H, Liang N, Wang Y, Liang C et al. Altered microRNA expression in patients with non-obstructive azoospermia. Reprod Biol Endocrinol 2009; 7: 13.
14. Bergmann M, Kliesch S. The distribution pattern of cytokeratin and vimentin immunoreactivity in testicular biopsies of infertile men. Anat Embryol (Berl) 1994; 190: 515-520. (Pubitemid 24359590)
15. Kroger A, Koster M, Schroeder K, Hauser H, Mueller PP. Activities of IRF-1. J Interferon Cytokine Res 2002; 22: 5-14. (Pubitemid 34161278)
16. Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M et al. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 1993; 259: 971-974. (Pubitemid 23080666)
17. Romeo G, Fiorucci G, Chiantore MV, Percario ZA, Vannucchi S, Affabris E. IRF-1 as a negative regulator of cell proliferation. J Interferon Cytokine Res 2002; 22: 39-47. (Pubitemid 34161281)
18. Kroger A, Stirnweiss A, Pulverer JE, Klages K, Grashoff M, Reimann J et al. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1. Cancer Res 2007; 67: 2972-2981. (Pubitemid 46724833)
19. Xie RL, Gupta S, Miele A, Shiffman D, Stein JL, Stein GS et al. The tumor suppressor interferon regulatory factor 1 interferes with SP1 activation to repress the human CDK2 promoter. J Biol Chem 2003; 278: 26589-26596. (Pubitemid 36876803)
20. Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW et al. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 1996; 382: 816-818. (Pubitemid 26299566)
21. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev 1997; 11: 847-862. (Pubitemid 27175292)
22. Brown KA, Roberts RL, Arteaga CL, Law BK. Transforming growth factor-beta induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor protein. Breast Cancer Res 2004; 6: R130-R139.
23. Yao G, Yin M, Lian J, Tian H, Liu L, Li X et al. MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Mol Endocrinol 2010; 24: 540-551.
24. Ashley T, Walpita D, de Rooij DG. Localization of two mammalian cyclin dependent kinases during mammalian meiosis. J Cell Sci 2001; 114: 685-693. (Pubitemid 32237141)
25. Tanaka N, Ishihara M, Taniguchi T. Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1. Cancer Lett 1994; 83: 191-196. (Pubitemid 24253537)
26. Chapman RS, Duff EK, Lourenco PC, Tonner E, Flint DJ, Clarke AR et al. A novel role for IRF-1 as a suppressor of apoptosis. Oncogene 2000; 19: 6386-6391. (Pubitemid 32641853)
27. Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 1993; 75: 83-97. (Pubitemid 23306023)
28. Jarvis S, Elliott DJ, Morgan D, Winston R, Readhead C. Molecular markers for the assessment of postnatal male germ cell development in the mouse. Hum Reprod 2005; 20: 108-116.
29. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-330.
30. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79: 551-555. (Pubitemid 24363798)
31. Guo J, Sheng G, Warner BW. Epidermal growth factor-induced rapid retinoblastoma phosphorylation at Ser780 and Ser795 is mediated by ERK1/2 in small intestine epithelial cells. J Biol Chem 2005; 280: 35992-35998. (Pubitemid 41633868)
32. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: cyclin D1: normal and abnormal functions. Endocrinology 2004; 145: 5439-5447. (Pubitemid 39564581)
33. Bartkova J, Rajpert-de Meyts E, Skakkebaek NE, Bartek J. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy. J Pathol 1999; 187: 573-581. (Pubitemid 29152000)
34. Houldsworth J, Reuter V, Bosl GJ, Chaganti RS. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell Growth Differ 1997; 8: 293-299. (Pubitemid 27273051)
35. Ikumasa TXZ, Yoshihiro K, Nobufumi U. The expression of cyclin D1 in the human testicular tissue. I. Immunohistochemical detection of cyclin D1 in the testicular tissue of infertile patients. Nishinihon J Urol 2001; 63: 79-82.
36. Strohmeyer T, Reissmann P, Cordon-Cardo C, Hartmann M, Ackermann R, Slamon D. Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Natl Acad Sci USA 1991; 88: 6662-6666. (Pubitemid 21915009)
37. Bartkova J, Lukas C, Sorensen CS, Meyts ER, Skakkebaek NE, Lukas J et al. Deregulation of the RB pathway in human testicular germ cell tumours. J Pathol 2003; 200: 149-156. (Pubitemid 36748023)
38. Walsh TJ, Croughan MS, Schembri M, Chan JM, Turek PJ. Increased risk of testicular germ cell cancer among infertile men. Arch Intern Med 2009; 169: 351-356.
39. Hotaling JM, Walsh TJ. Male infertility: a risk factor for testicular cancer. Nat Rev Urol 2009; 6: 550-556.
40. Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10: 1957-1966. (Pubitemid 39557833)